Cite
HARVARD Citation
Chen, P. et al. (2022). Dynamic changes in intrinsic subtype, immunity status, and risk score before and after neoadjuvant chemo- and HER2-targeted therapy without pCR in HER2-positive breast cancers: A cross-sectional analysis. Medicine. 101 (31), pp. e29877-. [Online].